GLP-3 (20 MG)

GLP-3 (20 MG)

Product Overview

GLP-3, also known as Retatrutide, is a next-generation triple receptor agonist studied for its powerful effects on metabolic regulation, weight management, and energy balance.
It activates GLP-1, GIP, and glucagon pathways simultaneously—three key hormonal circuits that influence appetite control, glucose metabolism, and fat utilization.
This tri-agonist design makes GLP-3 a breakthrough research compound for exploring multi-pathway mechanisms in metabolic health and energy expenditure.

Studies have shown that GLP-3 may support fat oxidation, improved insulin sensitivity, and enhanced satiety, resulting in more efficient metabolic function.
By targeting multiple receptor sites, it provides a dynamic model for studying synergistic hormonal signaling, lipid metabolism, and body composition optimization.
GLP-3 continues to draw research interest as a multi-pathway modulator for investigating next-generation approaches to obesity, metabolic balance, and glucose regulation.

Key Research Benefits

• Studied for its triple receptor activity on GLP-1, GIP, and glucagon pathways

• May support research into fat metabolism and energy expenditure

• Explored for its potential to enhance insulin sensitivity and satiety response

• Provides a multi-pathway model for studying metabolic regulation

• Investigated for applications in weight management and glucose control

• Represents a next-generation framework for metabolic and endocrine research

⚠️ Disclaimer

All products, including GLP-3 (Retatrutide), are sold for laboratory and research purposes only.
Not for human consumption, medical, or veterinary use.